Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 771 entries
Sorted by: Best Match Show Resources per page
Effects of tetrandrine and verapamil on fibroblastic growth and proliferation.

World journal of gastroenterology

Liu XS, Li DG, Lu HM, Wu QF.
PMID: 27041940
World J Gastroenterol. 1997 Jun 15;3(2):68. doi: 10.3748/wjg.v3.i2.68.

AIM: To investigate the effect of tetrandrine (Tet) and verapamil (Ver) on liver fibrosis by evaluating their effects on the growth and proliferation of fibroblasts.METHODS: Flow cytometry and imaging analysis were used to study the effects of combined and...

Cite
Liu XS, Li DG, Lu HM, et al. Effects of tetrandrine and verapamil on fibroblastic growth and proliferation. World J Gastroenterol. 1997;3(2):68doi: 10.3748/wjg.v3.i2.68.
Liu, X. S., Li, D. G., Lu, H. M., & Wu, Q. F. (1997). Effects of tetrandrine and verapamil on fibroblastic growth and proliferation. World journal of gastroenterology, 3(2), 68. https://doi.org/10.3748/wjg.v3.i2.68
Liu, X S, et al. "Effects of tetrandrine and verapamil on fibroblastic growth and proliferation." World journal of gastroenterology vol. 3,2 (1997): 68. doi: https://doi.org/10.3748/wjg.v3.i2.68
Liu XS, Li DG, Lu HM, Wu QF. Effects of tetrandrine and verapamil on fibroblastic growth and proliferation. World J Gastroenterol. 1997 Jun 15;3(2):68. doi: 10.3748/wjg.v3.i2.68. PMID: 27041940; PMCID: PMC4801925.
Copy Download .nbib Format: NLM
Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story.

Case reports in neurology

Rath CL, He J, Nordling MM, Wienecke T.
PMID: 28559833
Case Rep Neurol. 2017 May 05;9(1):98-105. doi: 10.1159/000474934. eCollection 2017.

Stroke mimics, like attacks of hemiplegic migraine, are challenging in acute stroke evaluation. We present a 28-year-old woman with a suspected hemiplegic migraine attack with left-sided hemiparalysis. Brain CT with perfusion imaging 1 h 54 min after symptom onset...

Cite
Rath CL, He J, Nordling MM, et al. Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story. Case Rep Neurol. 2017;9(1):98-105doi: 10.1159/000474934.
Rath, C. L., He, J., Nordling, M. M., & Wienecke, T. (2017). Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story. Case reports in neurology, 9(1), 98-105. https://doi.org/10.1159/000474934
Rath, Charlotte Lützhøft, et al. "Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story." Case reports in neurology vol. 9,1 (2017): 98-105. doi: https://doi.org/10.1159/000474934
Rath CL, He J, Nordling MM, Wienecke T. Acute Intravenous Calcium Antagonist for Suspected Hemiplegic Migraine - A Case Story. Case Rep Neurol. 2017 May 05;9(1):98-105. doi: 10.1159/000474934. eCollection 2017. PMID: 28559833; PMCID: PMC5437446.
Copy Download .nbib Format: NLM
Comparative Study on the MDR Reversal Effects of Selected Chalcones.

International journal of medicinal chemistry

Ivanova AB, Batovska DI, Todorova IT, Stamboliyska BA, Serly J, Molnar J.
PMID: 27516904
Int J Med Chem. 2011;2011:530780. doi: 10.1155/2011/530780. Epub 2010 Dec 29.

Based on the structure of three previously established lead compounds, fifteen selected chalcones were synthesized and evaluated for their multidrug resistance (MDR) reversal activity on mouse lymphoma cells. The most active chalcones were stronger revertants than the positive control,...

Cite
Ivanova AB, Batovska DI, Todorova IT, et al. Comparative Study on the MDR Reversal Effects of Selected Chalcones. Int J Med Chem. 2010;2011:530780doi: 10.1155/2011/530780.
Ivanova, A. B., Batovska, D. I., Todorova, I. T., Stamboliyska, B. A., Serly, J., & Molnar, J. (2011). Comparative Study on the MDR Reversal Effects of Selected Chalcones. International journal of medicinal chemistry, 2011530780. https://doi.org/10.1155/2011/530780
Ivanova, A B, et al. "Comparative Study on the MDR Reversal Effects of Selected Chalcones." International journal of medicinal chemistry vol. 2011 (2011): 530780. doi: https://doi.org/10.1155/2011/530780
Ivanova AB, Batovska DI, Todorova IT, Stamboliyska BA, Serly J, Molnar J. Comparative Study on the MDR Reversal Effects of Selected Chalcones. Int J Med Chem. 2011;2011:530780. doi: 10.1155/2011/530780. Epub 2010 Dec 29. PMID: 27516904; PMCID: PMC4970649.
Copy Download .nbib Format: NLM
Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.

Journal of atrial fibrillation

Barrios V, Escobar C.
PMID: 28496708
J Atr Fibrillation. 2011 Dec 20;4(4):423. doi: 10.4022/jafib.423. eCollection 2011 Dec.

A large percentage of patients with hypertension suffer from atrial fibrillation (AF). The concomitance of both conditions in the same patient markedly increases cardiovascular risk. Therefore, prevention of new-onset AF in hypertensive population should be a relevant target. High...

Cite
Barrios V, Escobar C. Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs. J Atr Fibrillation. 2011;4(4):423doi: 10.4022/jafib.423.
Barrios, V., & Escobar, C. (2011). Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs. Journal of atrial fibrillation, 4(4), 423. https://doi.org/10.4022/jafib.423
Barrios, Vivencio, and Escobar, Carlos. "Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs." Journal of atrial fibrillation vol. 4,4 (2011): 423. doi: https://doi.org/10.4022/jafib.423
Barrios V, Escobar C. Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs. J Atr Fibrillation. 2011 Dec 20;4(4):423. doi: 10.4022/jafib.423. eCollection 2011 Dec. PMID: 28496708; PMCID: PMC5153093.
Copy Download .nbib Format: NLM
Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins.

Frontiers in neurology

Sandow N, Kim S, Raue C, Päsler D, Klaft ZJ, Antonio LL, Hollnagel JO, Kovacs R, Kann O, Horn P, Vajkoczy P, Holtkamp M, Meencke HJ, Cavalheiro EA, Pragst F, Gabriel S, Lehmann TN, Heinemann U.
PMID: 25741317
Front Neurol. 2015 Feb 18;6:30. doi: 10.3389/fneur.2015.00030. eCollection 2015.

Drug resistant patients undergoing epilepsy surgery have a good chance to become sensitive to anticonvulsant medication, suggesting that the resected brain tissue is responsible for drug resistance. Here, we address the question whether P-glycoprotein (Pgp) and multidrug resistance-associated proteins...

Cite
Sandow N, Kim S, Raue C, et al. Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins. Front Neurol. 2015;6:30doi: 10.3389/fneur.2015.00030.
Sandow, N., Kim, S., Raue, C., Päsler, D., Klaft, Z. J., Antonio, L. L., Hollnagel, J. O., Kovacs, R., Kann, O., Horn, P., Vajkoczy, P., Holtkamp, M., Meencke, H. J., Cavalheiro, E. A., Pragst, F., Gabriel, S., Lehmann, T. N., & Heinemann, U. (2015). Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins. Frontiers in neurology, 630. https://doi.org/10.3389/fneur.2015.00030
Sandow, Nora, et al. "Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins." Frontiers in neurology vol. 6 (2015): 30. doi: https://doi.org/10.3389/fneur.2015.00030
Sandow N, Kim S, Raue C, Päsler D, Klaft ZJ, Antonio LL, Hollnagel JO, Kovacs R, Kann O, Horn P, Vajkoczy P, Holtkamp M, Meencke HJ, Cavalheiro EA, Pragst F, Gabriel S, Lehmann TN, Heinemann U. Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins. Front Neurol. 2015 Feb 18;6:30. doi: 10.3389/fneur.2015.00030. eCollection 2015. PMID: 25741317; PMCID: PMC4332373.
Copy Download .nbib Format: NLM
Tetracyclines, verapamil and nifedipine induce callose deposition at specific cell sites in Riella helicophylla.

Planta

Grotha R.
PMID: 24232763
Planta. 1986 Dec;169(4):546-54. doi: 10.1007/BF00392105.

The Ca(2+) indicator 7-chlorotetracycline has been shown to bind to a pore complex on both outer surfaces of all non-meristematic cells in the unistratose thallus of Riella ('chlorotetracycline-binding surface region'=CSR; Grotha, 1983, Planta 158, 473-481). Prolonged treatment of the...

Cite
Grotha R. Tetracyclines, verapamil and nifedipine induce callose deposition at specific cell sites in Riella helicophylla. Planta. 1986;169(4):546-54doi: 10.1007/BF00392105.
Grotha, R. (1986). Tetracyclines, verapamil and nifedipine induce callose deposition at specific cell sites in Riella helicophylla. Planta, 169(4), 546-54. https://doi.org/10.1007/BF00392105
Grotha, R. "Tetracyclines, verapamil and nifedipine induce callose deposition at specific cell sites in Riella helicophylla." Planta vol. 169,4 (1986): 546-54. doi: https://doi.org/10.1007/BF00392105
Grotha R. Tetracyclines, verapamil and nifedipine induce callose deposition at specific cell sites in Riella helicophylla. Planta. 1986 Dec;169(4):546-54. doi: 10.1007/BF00392105. PMID: 24232763.
Copy Download .nbib Format: NLM
A comparison of verapamil and digoxin for heart rate control in atrial fibrillation.

Advanced pharmaceutical bulletin

Afzali Moghadam M, Fadaie Dashti M, Shahsavarinia K, Mahmoodpoor A, Jamali K.
PMID: 24312794
Adv Pharm Bull. 2012;2(2):201-5. doi: 10.5681/apb.2012.031. Epub 2012 Aug 15.

PURPOSE: Atrial fibrillation (AF) is one of the most common types of sustained dysrhythmia and there are some disagreements about its treatment. The goals of AF treatment include the control of ventricular rate, the establishment of sinus rhythm and...

Cite
Afzali Moghadam M, Fadaie Dashti M, Shahsavarinia K, et al. A comparison of verapamil and digoxin for heart rate control in atrial fibrillation. Adv Pharm Bull. 2012;2(2):201-5doi: 10.5681/apb.2012.031.
Afzali Moghadam, M., Fadaie Dashti, M., Shahsavarinia, K., Mahmoodpoor, A., & Jamali, K. (2012). A comparison of verapamil and digoxin for heart rate control in atrial fibrillation. Advanced pharmaceutical bulletin, 2(2), 201-5. https://doi.org/10.5681/apb.2012.031
Afzali Moghadam, Mohammad, et al. "A comparison of verapamil and digoxin for heart rate control in atrial fibrillation." Advanced pharmaceutical bulletin vol. 2,2 (2012): 201-5. doi: https://doi.org/10.5681/apb.2012.031
Afzali Moghadam M, Fadaie Dashti M, Shahsavarinia K, Mahmoodpoor A, Jamali K. A comparison of verapamil and digoxin for heart rate control in atrial fibrillation. Adv Pharm Bull. 2012;2(2):201-5. doi: 10.5681/apb.2012.031. Epub 2012 Aug 15. PMID: 24312794; PMCID: PMC3846001.
Copy Download .nbib Format: NLM
Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil.

Indian journal of psychological medicine

Settem JV, Trivedi S, Kamath AG, Behere RV, Kanaradi H, Bhat SM.
PMID: 26664091
Indian J Psychol Med. 2015 Jul-Sep;37(3):358-9. doi: 10.4103/0253-7176.162925.

Clozapine is known to be an effective antipsychotic for schizophrenia. Cardiovascular complications associated with initiation of clozapine include tachycardia, postural hypotension, and myocarditis. Factors associated with development of cardiovascular adverse events are not clearly known, and dose titration has...

Cite
Settem JV, Trivedi S, Kamath AG, et al. Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil. Indian J Psychol Med. 2015;37(3):358-9doi: 10.4103/0253-7176.162925.
Settem, J. V., Trivedi, S., Kamath, A. G., Behere, R. V., Kanaradi, H., & Bhat, S. M. (2015). Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil. Indian journal of psychological medicine, 37(3), 358-9. https://doi.org/10.4103/0253-7176.162925
Settem, Jagadeesh V V, et al. "Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil." Indian journal of psychological medicine vol. 37,3 (2015): 358-9. doi: https://doi.org/10.4103/0253-7176.162925
Settem JV, Trivedi S, Kamath AG, Behere RV, Kanaradi H, Bhat SM. Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil. Indian J Psychol Med. 2015 Jul-Sep;37(3):358-9. doi: 10.4103/0253-7176.162925. PMID: 26664091; PMCID: PMC4649798.
Copy Download .nbib Format: NLM
Does P-glycoprotein play a role in anticancer drug pharmacokinetics?.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Sparreboom A, Nooter K.
PMID: 11498403
Drug Resist Updat. 2000 Dec;3(6):357-363. doi: 10.1054/drup.2000.0164.

The multidrug-resistance P-glycoprotein is a drug efflux transport protein abundantly present in various types of human cancer. The protein is encoded by the MDR1 gene and its function is sensitive to modulation by competitive inhibition. Clinical studies have indicated...

Cite
Sparreboom A, Nooter K. Does P-glycoprotein play a role in anticancer drug pharmacokinetics?. Drug Resist Updat. 2000;3(6):357-363doi: 10.1054/drup.2000.0164.
Sparreboom, A., & Nooter, K. (2000). Does P-glycoprotein play a role in anticancer drug pharmacokinetics?. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 3(6), 357-363. https://doi.org/10.1054/drup.2000.0164
Sparreboom, Alex, and Nooter, Kees. "Does P-glycoprotein play a role in anticancer drug pharmacokinetics?." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 3,6 (2000): 357-363. doi: https://doi.org/10.1054/drup.2000.0164
Sparreboom A, Nooter K. Does P-glycoprotein play a role in anticancer drug pharmacokinetics?. Drug Resist Updat. 2000 Dec;3(6):357-363. doi: 10.1054/drup.2000.0164. PMID: 11498403.
Copy Download .nbib Format: NLM
Primary prevention of coronary heart disease in hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension

Sleight P.
PMID: 8934376
J Hypertens Suppl. 1996 Sep;14(2):S35-8; discussion S38-9. doi: 10.1097/00004872-199609002-00009.

MORTALITY FROM MYOCARDIAL INFARCTION: Primary prevention of coronary heart disease in hypertension is important because the mortality among those who have suffered a myocardial infarction is around 50% within 1 month of the infarction. Although the mortality of those...

Cite
Sleight P. Primary prevention of coronary heart disease in hypertension. J Hypertens Suppl. 1996;14(2):S35-8; discussion S38-9doi: 10.1097/00004872-199609002-00009.
Sleight, P. (1996). Primary prevention of coronary heart disease in hypertension. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 14(2), S35-8; discussion S38-9. https://doi.org/10.1097/00004872-199609002-00009
Sleight, P. "Primary prevention of coronary heart disease in hypertension." Journal of hypertension. Supplement : official journal of the International Society of Hypertension vol. 14,2 (1996): S35-8; discussion S38-9. doi: https://doi.org/10.1097/00004872-199609002-00009
Sleight P. Primary prevention of coronary heart disease in hypertension. J Hypertens Suppl. 1996 Sep;14(2):S35-8; discussion S38-9. doi: 10.1097/00004872-199609002-00009. PMID: 8934376.
Copy Download .nbib Format: NLM
Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil.

American journal of therapeutics

Cobb MM, Johnson D, Gallo J, Crawley JA, Cargo PH, Lefkowitz MP.
PMID: 11850691
Am J Ther. 1995 Jul;2(7):455-461. doi: 10.1097/00045391-199506000-00003.

BACKGROUND: In general clinical practice, physicians prescribe calcium channel blockers to a wide range of patients with differing demographic characteristics and hypertension history. This study was undertaken to investigate the effectiveness and safety of sustained-release verapamil (Verelan((R)), verapamil HCl)...

Cite
Cobb MM, Johnson D, Gallo J, et al. Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. Am J Ther. 1995;2(7):455-461doi: 10.1097/00045391-199506000-00003.
Cobb, M. M., Johnson, D., Gallo, J., Crawley, J. A., Cargo, P. H., & Lefkowitz, M. P. (1995). Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. American journal of therapeutics, 2(7), 455-461. https://doi.org/10.1097/00045391-199506000-00003
Cobb, Margaret M., et al. "Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil." American journal of therapeutics vol. 2,7 (1995): 455-461. doi: https://doi.org/10.1097/00045391-199506000-00003
Cobb MM, Johnson D, Gallo J, Crawley JA, Cargo PH, Lefkowitz MP. Large-Scale Postmarketing Surveillance of Hypertensive Patients Treated with Verapamil. Am J Ther. 1995 Jul;2(7):455-461. doi: 10.1097/00045391-199506000-00003. PMID: 11850691.
Copy Download .nbib Format: NLM
Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension.

American journal of therapeutics

Franklin SS, Smith DH, Codispoti J, Stokes A, McNally C, Weber MA.
PMID: 11862255
Am J Ther. 1996 Mar;3(3):229-236. doi: 10.1097/00045391-199603000-00009.

A multicenter study of the treatment of mild and moderate hypertension compared three once-daily regimens for efficacy and safety: Group I, verapamil sustained release (SR) 240 mg; Group II, verapamil SR 480 mg; and Group III, verapamil SR 240...

Cite
Franklin SS, Smith DH, Codispoti J, et al. Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension. Am J Ther. 1996;3(3):229-236doi: 10.1097/00045391-199603000-00009.
Franklin, S. S., Smith, D. H., Codispoti, J., Stokes, A., McNally, C., & Weber, M. A. (1996). Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension. American journal of therapeutics, 3(3), 229-236. https://doi.org/10.1097/00045391-199603000-00009
Franklin, Stanley S., et al. "Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension." American journal of therapeutics vol. 3,3 (1996): 229-236. doi: https://doi.org/10.1097/00045391-199603000-00009
Franklin SS, Smith DH, Codispoti J, Stokes A, McNally C, Weber MA. Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension. Am J Ther. 1996 Mar;3(3):229-236. doi: 10.1097/00045391-199603000-00009. PMID: 11862255.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 771 entries